Is there a strategy for preventing bronchopulmonary dysplasia? Absence of evidence is not evidence of absence.
Aly
Hany
H
Department of Newborn Services, George Washington University and Children's National Medical Center, Washington, DC, USA. haly@mfa.gwu.edu
D001997:Bronchopulmonary Dysplasia / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D019317:Evidence-Based Medicine; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007363:Intensive Care Units, Neonatal; D008297:Male; D009359:Neonatology / Q000592:standards / Q000639:trends; D010102:Oxygen Inhalation Therapy / Q000009:adverse effects* / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D012121:Respiration, Artificial / Q000009:adverse effects* / Q000379:methods; D012127:Respiratory Distress Syndrome, Newborn / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D018570:Risk Assessment; D015996:Survival Rate; D014481:United States